← Insider buys
ARQT

Arcutis Biotherapeutics, Inc. · Healthcare

Director Patrick J Heron bought $35K of Arcutis Biotherapeutics, Inc.

Bought$34,610
$13.08Price
2,646Shares

What ARQT did for a copier

Filed Jun 17Copier in Jun 18
$1,000 copied at Wed, Jun 18 open, $13.35
$1,070
S&P 500, same days
+4.2%

Measured over 30 trading days, to the Aug 1 close.

Patrick J Heron's record

15 other buys with 3 months of prices since 2020: on average +4.8% against the S&P 500, and 9 of 15 beat it.

We're building an app that can copy buys like this into your own brokerage. Join the waitlist

Traded Fri, Jun 13. Filed Tue, Jun 17, 5:45 PM ET, after the close. Returns use the Jun 18 open and the Aug 1 close. Not investment advice.